An economic evaluation of antihypertensive therapies based on clinical trials.

about

An economic evaluation of antihypertensive therapies based on clinical trials.

Item

http://www.wikidata.org/entity/Q35641729

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

An economic evaluation of antihypertensive therapies based on clinical trials.

@ast

An economic evaluation of antihypertensive therapies based on clinical trials.

@en

type

Item

label

An economic evaluation of antihypertensive therapies based on clinical trials.

@ast

An economic evaluation of antihypertensive therapies based on clinical trials.

@en

prefLabel

An economic evaluation of antihypertensive therapies based on clinical trials.

@ast

An economic evaluation of antihypertensive therapies based on clinical trials.

@en

P1476

An economic evaluation of antihypertensive therapies based on clinical trials.

@en

P2093

Decio Mion Júnior

http://www.w3.org/2001/XMLSchema#string

Giovanio Vieira da Silva

http://www.w3.org/2001/XMLSchema#string

Katia Coelho Ortega

http://www.w3.org/2001/XMLSchema#string

Otavio Berwanger

http://www.w3.org/2001/XMLSchema#string

Rosana Lima Garcia Tsuji

http://www.w3.org/2001/XMLSchema#string

P2860

Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents.

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

How to avoid discontinuation of antihypertensive treatment: The experience in São Paulo, Brazil.

Economics of antihypertensive therapy in the elderly.

Pharmacoeconomic challenges in disease management of hypertension.

Thiazide diuretics: first-line therapy for hypertension.

Pharmacoeconomic burden of undertreating hypertension.

Cost-effectiveness of hypertension treatment: a population-based study.

Antihypertensive therapy: how to evaluate the benefits.

P304

41-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6061/CLINICS/2012(01)07

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221751614

http://www.w3.org/2001/XMLSchema#string

P698

22249479

http://www.w3.org/2001/XMLSchema#string

P932

3248600

http://www.w3.org/2001/XMLSchema#string